Metopio Inc.

Metopio is a data analytics platform that enhances community health assessments and improvement plans, dramatically expediting data processes for public health organizations. Metopio is a data analytics technology company focusing on streamlining community health assessments (CHA) and community health improvement plans (CHIP). Founded in 2019, the firm is headquartered in Chicago, US. The founder, whose previous ventures are not mentioned, established Metopio to address inefficiencies in health data processing.

Metopio has completed a total of 1 deal, with its most recent deal occurring on April 7, 2025. Metopio offers a data analytics platform specifically designed to streamline community health assessments (CHA) and community health improvement plans (CHIP). Their core product enables organizations to automate the health assessment process, significantly reducing the time required for data collection and analysis—from traditional timelines of 9-12 months to just 30 minutes. This platform provides instant access to curated, ready-to-use community health data, allowing users to quickly interpret feedback through AI-powered qualitative analysis.

The end users of Metopio’s services include local health departments, community organizations, and public health entities across various geographical markets in the United States and beyond, focusing on improving community health outcomes through enhanced data-driven decision-making. Metopio's revenue model is primarily based on subscription services, allowing clients to access their health analytics platform. Clients typically enter into service agreements that enable them to utilize the Metopio platform for conducting health assessments and developing improvement plans. The pricing structure includes tiered subscription models based on the scale of user engagement and the depth of data analytics services utilized.

Partnerships, such as collaborations with the National Association of County and City Health Officials (NACCHO), also contribute to expanding Metopio's revenue opportunities by providing access to a broader network of local health departments. Through these arrangements, Metopio helps clients navigate community health challenges while generating revenue from its flagship data analytics services. In April 2025, Metopio raised an undisclosed amount of growth capital funding led by new investor Plymouth Growth Partners. The company will utilize this funding to expand data access, allowing healthcare and public health professionals to make faster, more informed decisions that have a direct impact on community health.

Metopio plans to enhance its product offerings with new features designed to improve user experience and outcomes, although specific launch dates for these products have not been disclosed. The firm aims to penetrate additional geographic markets across the United States, focusing on regions with high public health needs, although specific targets are yet to be determined.